vs
Side-by-side financial comparison of INSEEGO CORP. (INSG) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $48.4M, roughly 1.7× INSEEGO CORP.). INSEEGO CORP. runs the higher net margin — 1.0% vs -38.1%, a 39.0% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 0.6%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 13.6%).
Inseego Corp designs, manufactures and delivers advanced 5G and IoT solutions including mobile hotspots, edge computing devices, and cloud-based device management platforms. It primarily serves telecom operators, enterprise clients, and public sector customers across global markets.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
INSG vs PRCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $48.4M | $83.1M |
| Net Profit | $469.0K | $-31.6M |
| Gross Margin | 42.2% | 64.9% |
| Operating Margin | 2.7% | -4.1% |
| Net Margin | 1.0% | -38.1% |
| Revenue YoY | 0.6% | 20.2% |
| Net Profit YoY | 182.9% | -27.9% |
| EPS (diluted) | $-0.02 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $48.4M | $76.4M | ||
| Q3 25 | $45.9M | $83.3M | ||
| Q2 25 | $40.2M | $79.2M | ||
| Q1 25 | $31.7M | $69.2M | ||
| Q4 24 | $48.1M | $68.2M | ||
| Q3 24 | $54.0M | $58.4M | ||
| Q2 24 | $51.6M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $469.0K | $-29.8M | ||
| Q3 25 | $1.4M | $-21.4M | ||
| Q2 25 | $507.0K | $-19.6M | ||
| Q1 25 | $-1.6M | $-24.7M | ||
| Q4 24 | $-566.0K | $-18.9M | ||
| Q3 24 | $9.0M | $-21.0M | ||
| Q2 24 | $624.0K | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | 42.2% | 60.6% | ||
| Q3 25 | 41.6% | 64.8% | ||
| Q2 25 | 41.1% | 65.4% | ||
| Q1 25 | 47.3% | 63.9% | ||
| Q4 24 | 37.3% | 64.0% | ||
| Q3 24 | 34.8% | 63.2% | ||
| Q2 24 | 36.4% | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | 2.7% | -40.6% | ||
| Q3 25 | 4.7% | -27.8% | ||
| Q2 25 | 3.2% | -28.0% | ||
| Q1 25 | -1.3% | -39.7% | ||
| Q4 24 | 3.7% | -28.9% | ||
| Q3 24 | 1.9% | -38.4% | ||
| Q2 24 | 3.6% | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | 1.0% | -39.1% | ||
| Q3 25 | 3.1% | -25.7% | ||
| Q2 25 | 1.3% | -24.7% | ||
| Q1 25 | -5.0% | -35.8% | ||
| Q4 24 | -1.2% | -27.6% | ||
| Q3 24 | 16.6% | -35.9% | ||
| Q2 24 | 1.2% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $-0.02 | $-0.54 | ||
| Q3 25 | $0.03 | $-0.38 | ||
| Q2 25 | $-0.03 | $-0.35 | ||
| Q1 25 | $-0.16 | $-0.45 | ||
| Q4 24 | $0.62 | $-0.34 | ||
| Q3 24 | $-0.06 | $-0.40 | ||
| Q2 24 | $-0.02 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $24.9M | $245.6M |
| Total DebtLower is stronger | — | $51.7M |
| Stockholders' EquityBook value | $-4.0M | $347.7M |
| Total Assets | $93.8M | $487.1M |
| Debt / EquityLower = less leverage | — | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | $24.9M | $286.5M | ||
| Q3 25 | $14.6M | $294.3M | ||
| Q2 25 | $13.2M | $302.7M | ||
| Q1 25 | $35.1M | $316.2M | ||
| Q4 24 | $39.6M | $333.7M | ||
| Q3 24 | $12.0M | $196.8M | ||
| Q2 24 | $49.0M | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | — | $51.6M | ||
| Q3 25 | — | $51.6M | ||
| Q2 25 | — | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $-4.0M | $365.9M | ||
| Q3 25 | $-7.7M | $380.3M | ||
| Q2 25 | $-10.5M | $385.8M | ||
| Q1 25 | $-13.0M | $389.2M | ||
| Q4 24 | $-12.9M | $402.2M | ||
| Q3 24 | $-85.1M | $241.2M | ||
| Q2 24 | $-101.8M | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $93.8M | $508.1M | ||
| Q3 25 | $85.8M | $511.5M | ||
| Q2 25 | $83.1M | $513.1M | ||
| Q1 25 | $93.0M | $519.4M | ||
| Q4 24 | $100.0M | $534.0M | ||
| Q3 24 | $113.4M | $374.1M | ||
| Q2 24 | $149.6M | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.0M | — |
| Free Cash FlowOCF − Capex | $11.6M | — |
| FCF MarginFCF / Revenue | 24.0% | — |
| Capex IntensityCapex / Revenue | 0.7% | — |
| Cash ConversionOCF / Net Profit | 25.50× | — |
| TTM Free Cash FlowTrailing 4 quarters | $6.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $12.0M | $-10.3M | ||
| Q3 25 | $3.2M | $-6.6M | ||
| Q2 25 | $-4.5M | $-15.0M | ||
| Q1 25 | $-3.5M | $-17.0M | ||
| Q4 24 | $-14.2M | $-32.4M | ||
| Q3 24 | $14.8M | $-18.8M | ||
| Q2 24 | $27.6M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | $11.6M | $-12.2M | ||
| Q3 25 | $3.1M | $-9.5M | ||
| Q2 25 | $-4.7M | $-17.8M | ||
| Q1 25 | $-3.5M | $-18.8M | ||
| Q4 24 | $-14.3M | $-33.6M | ||
| Q3 24 | $14.8M | $-19.0M | ||
| Q2 24 | $27.6M | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | 24.0% | -15.9% | ||
| Q3 25 | 6.7% | -11.4% | ||
| Q2 25 | -11.6% | -22.5% | ||
| Q1 25 | -11.0% | -27.2% | ||
| Q4 24 | -29.7% | -49.2% | ||
| Q3 24 | 27.4% | -32.6% | ||
| Q2 24 | 53.5% | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | 0.7% | 2.4% | ||
| Q3 25 | 0.2% | 3.4% | ||
| Q2 25 | 0.5% | 3.5% | ||
| Q1 25 | 0.1% | 2.7% | ||
| Q4 24 | 0.1% | 1.7% | ||
| Q3 24 | 0.0% | 0.4% | ||
| Q2 24 | 0.0% | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | 25.50× | — | ||
| Q3 25 | 2.22× | — | ||
| Q2 25 | -8.81× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.65× | — | ||
| Q2 24 | 44.31× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
INSG
Segment breakdown not available.
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
